What benefit-risk trade-offs are acceptable to rheumatoid arthritis patients during treatment selection? Evidence from a multicountry choice experiment.
Rieke E AltenJuan Carlos Nieto-GonzalezPeggy JacquesCarlomaurizio MontecuccoRobert MootsHelga RadnerHarald E VonkemanSebastian HeidenreichChiara WhichelloNicolas KrucienKatrien Van BenedenPublished in: RMD open (2024)
Treatment preferences of patients with RA were individual-specific, but driven by benefits and risks, with no single attribute dominating the decision-making.